More emphasis should be given on investing healthcare resources towards prevention of diseases rather than only focusing on diagnostic and therapeutic options
Ajanta Pharma has reported total income of Rs. 1,171.39 crores during the period ended June 30, 2024
Performed an autologous bone marrow transplant, using the patient’s own cells to reduce the chances of infection and rejection
Granules India has reported total income of Rs. 1181.92 crores during the period ended June 30, 2024
Boehringer Ingelheim aims to develop this program as a potential key centerpiece component for its immuno-oncology portfolio
The acquisition will further strengthen Barentz’ position in India creating a leading life science distribution platform
BAV has revolutionized the animal vaccination industry with its ground-breaking delivery methods that prioritize quality, safety, and efficacy
Decision on EU marketing authorisation for this population expected by September 2024
Dr. Reddy's had previously received the EU GMP certificate for its Rituximab drug substance
Pfizer Ltd. has reported total income of Rs. 604.70 crores during the period ended June 30, 2024
Subscribe To Our Newsletter & Stay Updated
